Inovio Pharmaceuticals
INO
#8890
Rank
S$0.18 B
Marketcap
S$2.75
Share price
-1.84%
Change (1 day)
-49.17%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): S-$3.73

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.72. In 2024 the company made an earnings per share (EPS) of S-$5.10 an increase over its 2023 EPS that were of S-$7.86.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.73-26.95%
2024S-$5.10-35.14%
2023S-$7.86-56.62%
2022S-$18.13-19.54%
2021S-$22.5435.9%
2020S-$16.58-11.57%
2019S-$18.7515.24%
2018S-$16.27-2.78%
2017S-$16.746.93%
2016S-$15.65134.88%
2015S-$6.66-29.51%
2014S-$9.45-57.34%
2013S-$22.16146.55%
2012S-$8.9920.83%
2011S-$7.44-29.41%
2010S-$10.54-48.48%
2009S-$20.4610%
2008S-$18.6011.11%
2007S-$16.74-41.3%
2006S-$28.51-66.91%
2005S-$86.16110.61%
2004S-$40.91-61.63%
2003S-$106.62186.67%
2002S-$37.19
2001N/A-100%
2000S-$29.75-63.64%
1999S-$81.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.22-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.48-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S-$1.61-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.50-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.81-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.64-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
S$8.42-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA